Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...

Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

A study reveals the potential use of cannabis in biblical times, suggesting Jesus used it for healing and anointing practices ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.8, a high estimate of $46.00 ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $318.33, ...

Analysts have set 12-month price targets for Ultragenyx Pharmaceutical, revealing an average target of $89.7, a high estimate ...

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.8, a high ...

The general mood among these heavyweight investors is divided, with 0% leaning bullish and 62% bearish. Among these notable ...

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Today, Benzinga's options scanner spotted 12 options trades for SoFi Techs. This is not a typical pattern. The sentiment ...